A Phase 1 Study of the Absorption, Metabolism, and Excretion of [14C] PBI-200

Key Inclusion Criteria: * Males, of any race, 18 to 65 years of age as of the dosing day. * Body mass index between 18.0 and 32.0 kg/m2, inclusive. * Non-smoking/non-vaping, healthy, with no history of clinically relevant medical illness. Key Exclusion Criteria: * Significant history or clinical manifestation of any metabolic, allergic, dermatological, hepatic, renal, hematological, pulmonary, cardiovascular, gastrointestinal, neurological, respiratory, endocrine, or psychiatric disorder. * History of significant hypersensitivity, intolerance, or allergy to any drug compound, food, or other substance. * History of stomach or intestinal surgery or resection that would potentially alter absorption and/or excretion of orally administered drugs (uncomplicated appendectomy and hernia repair will be allowed).